Apeximmune Therapeutics


Apeximmune seeks to be a preeminent leader in the discovery and development of novel biologics that modulate the immune system for the treatment of a broad spectrum of indications including cancer, autoimmune disease, and transplantation.

​​We focus on the science underlying what we believe to be the most powerful biological mechanisms driving disease pathophysiology. Our technology platform combines bioinformatics with biological assays to enable identification of novel immune modulating targets. With a team encompassing expertise in immunology, cellular and molecular tumor biology, protein characterization and optimization, and pharmacokinetics, we are developing biologics/antibodies to treat disease through these mechanisms.

Company Information

April 19, 2022